HHS Sec. Robert F. Kennedy, Jr. and Sen. Markwayne Mullin (R-OK), along with FDA Commissioner Dr. Marty Makary, announce new ...

Federal officials said a psychoactive ingredient in kratom had been refined and added to supplements that could quickly ...

The Food and Drug Administration is considering adding warning labels to antidepressants for women who are pregnant, despite ...

The Food and Drug Administration on Tuesday recommended classifying 7-OH, a compound with opioid-like effects found in ...

The Food and Drug Administration has expanded a recall involving ready-to-eat items made with tuna salad. The recall involves ...

Numerous recalls have been initiated in 2025 due to the potential for damaged products, foodborne illness, contamination and ...

In recent months, dietary supplement companies that sell kratom have been urging the Food and Drug Administration to crack ...

Dangerous products are marketed as “kratom extract” or “enhanced kratom” and often disguised as candies, gummies and even ice ...

Food and Drug Administrator Commissioner Marty Makary has requested that the Drug Enforcement Administration classify 7-OH as ...

OH, a synthetic opioid more potent than morphine derived from kratom, amid rising medical events and addiction concerns ...

Sarepta stock soared after the FDA said the biotech company can resume shipments of a controversial gene therapy drug.

Sarepta Therapeutics Inc. shares rose sharply early Tuesday after US regulators reversed course and recommended that patients who can walk be allowed to take its gene therapy Elevidys again.